Concepedia

NSCLC, metastatic CheckMate 026: A phase 3 trial of nivolumab vs investigator's choice (IC) of platinum-based doublet chemotherapy (PT-DC) as first-line therapy for stage iv/recurrent programmed death ligand 1 (PD-L1)−positive NSCLC

Mark A. Socinski, Ben Creelan, Leora Horn, Martin Reck, Luis Paz‐Ares, Martin Steins, Enriqueta Felip, Michel M. van den Heuvel, Tudor–Eliade Ciuleanu, Firas Badin,

Annals of Oncology · 2016 · 111 citations · 0 references

Open access